Doctors ask: should we offer HIV prevention pills at routine checkups?

NCT ID NCT06930508

Summary

This study aims to find out if it's practical and acceptable to offer HIV prevention medication (PrEP) during routine visits at a family planning clinic. Researchers will ask about 83 patients and their doctors to try a new process for discussing and starting PrEP during regular appointments. The goal is to understand what makes it easier or harder to offer this preventive care in this setting.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Women and Infants Hospital of Rhode Island

    Providence, Rhode Island, 02905, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.